Real‐World Outcomes of Total Neoadjuvant Therapy Versus Standard Neoadjuvant Chemoradiotherapy in Stage II–III Locally Advanced Rectal Cancer: A Comparative Cohort Study

Documenti analoghi

• Clinical–Pathologic Response Discordance After Neoadjuvant Therapy in Rectal Cancer and Its Prognostic Implications
  di: Aysun Arslantas Erken, et al.
  Pubblicazione: (2026)
• Impact of Metformin and Diabetes on Tumor Response to Total Neoadjuvant Therapy in Advanced Rectal Cancer: A Multicenter Retrospective Cohort Study
  di: Sergei Bedrikovetski, et al.
  Pubblicazione: (2026)
• Real‐World Outcomes of Patients Treated With Neoadjuvant Imatinib for Locally Advanced, Recurrent and Limited Metastatic Gastrointestinal Stromal Tumour in an Australian Cancer Training Network
  di: Amy E. Smith, et al.
  Pubblicazione: (2025)
• Neoadjuvant Chemotherapy With Chemoradiotherapy for Patients With Borderline Resectable or Locally Advanced Pancreatic Ductal Adenocarcinoma—Retrospective Review From a Tertiary Care Hospital
  di: Avtaj Nerwal, et al.
  Pubblicazione: (2025)
• Perspectives of the Use of Neoadjuvant Therapy in the Management of Locally Advanced and Locally Recurrent Colon Cancer: A Bi‐National Survey of Colorectal Surgeons
  di: Rathin Gosavi, et al.
  Pubblicazione: (2025)